$1.50
+0.06 (+4.17%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,988.0% upside
Low Target
$21.60
Average Target
$31.32
High Target
$37.71
Current Price
$1.50
Current
$1.50
$1.50
Target
$31.32
$31.32
$21.60
$31.32 avg
$37.71
Scenario Analysis
Bear Case
$21.60
1,340.0%
Low target
Base Case
$31.32
+1,988.0%
Avg target
Bull Case
$37.71
+2,414.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.23
-32.7% from high
52-Week Low
$0.85
+76.5% from low
Target vs 52W High
$31.32
+1,304.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |